Baerveldt glaucoma implant in paediatric patients

K A van Overdam; J T H N de Faber; H G Lemij; P W T de Waard

doi:10.1136/bjo.2005.078832

Baerveldt glaucoma implant in paediatric patients

K A van Overdam, J T H N de Faber, H G Lemij, P W T de Waard

Research output: Contribution to journal › Article › Research › peer-review

Abstract

AIM: To evaluate the Baerveldt glaucoma implant (BGI) in paediatric glaucoma treatment.

METHODS: In a retrospective non-comparative case series 55 eyes of 40 consecutive paediatric patients (< or =16 years) with primary or secondary glaucoma underwent Baerveldt (350 mm2) implantation. Surgical outcome was evaluated by Kaplan-Meier table analysis.

RESULTS: The overall success rate was 80% at last follow up, with a mean follow up of 32 (range 2-78) months. Cumulative success was 94% at 12 months and 24 months, 85% at 36 months, 78% at 48 months, and 44% at 60 months. 11 eyes (20%) failed postoperatively because of an IOP >21 mm Hg (eight eyes), persistent hypotony (two eyes), and choroidal haemorrhage following cataract surgery (one eye). The most frequent complication needing surgery was tube related (20%). A new observation was mild to moderate dyscoria in 22% of the eyes, all buphthalmic, caused by entrapment of a tuft of peripheral iris in the tube track.

CONCLUSIONS: The BGI is effective and safe in the management of primary and secondary glaucoma. When angle surgery has proved to be unsuccessful or inappropriate in paediatric patients, a BGI is a good treatment option. One must be prepared to deal with the tube related problems.

Original language	English
Pages (from-to)	328-32
Number of pages	5
Journal	British Journal of Ophthalmology
Volume	90
Issue number	3
DOIs	https://doi.org/10.1136/bjo.2005.078832
Publication status	Published - Mar 2006

Keywords

Adolescent
Antihypertensive Agents/administration & dosage
Child
Child, Preschool
Combined Modality Therapy
Filtering Surgery/methods
Glaucoma/congenital
Glaucoma Drainage Implants/adverse effects
Humans
Infant
Infant, Newborn
Intraocular Pressure
Prosthesis Implantation/methods
Reoperation
Retrospective Studies
Treatment Failure
Treatment Outcome

Access to Document

10.1136/bjo.2005.078832

Cite this

@article{c8e0fda44fd2490494f70c3dddb5c2da,

title = "Baerveldt glaucoma implant in paediatric patients",

abstract = "AIM: To evaluate the Baerveldt glaucoma implant (BGI) in paediatric glaucoma treatment.METHODS: In a retrospective non-comparative case series 55 eyes of 40 consecutive paediatric patients (< or =16 years) with primary or secondary glaucoma underwent Baerveldt (350 mm2) implantation. Surgical outcome was evaluated by Kaplan-Meier table analysis.RESULTS: The overall success rate was 80% at last follow up, with a mean follow up of 32 (range 2-78) months. Cumulative success was 94% at 12 months and 24 months, 85% at 36 months, 78% at 48 months, and 44% at 60 months. 11 eyes (20%) failed postoperatively because of an IOP >21 mm Hg (eight eyes), persistent hypotony (two eyes), and choroidal haemorrhage following cataract surgery (one eye). The most frequent complication needing surgery was tube related (20%). A new observation was mild to moderate dyscoria in 22% of the eyes, all buphthalmic, caused by entrapment of a tuft of peripheral iris in the tube track.CONCLUSIONS: The BGI is effective and safe in the management of primary and secondary glaucoma. When angle surgery has proved to be unsuccessful or inappropriate in paediatric patients, a BGI is a good treatment option. One must be prepared to deal with the tube related problems.",

keywords = "Adolescent, Antihypertensive Agents/administration & dosage, Child, Child, Preschool, Combined Modality Therapy, Filtering Surgery/methods, Glaucoma/congenital, Glaucoma Drainage Implants/adverse effects, Humans, Infant, Infant, Newborn, Intraocular Pressure, Prosthesis Implantation/methods, Reoperation, Retrospective Studies, Treatment Failure, Treatment Outcome",

author = "{van Overdam}, {K A} and {de Faber}, {J T H N} and Lemij, {H G} and {de Waard}, {P W T}",

year = "2006",

month = mar,

doi = "10.1136/bjo.2005.078832",

language = "English",

volume = "90",

pages = "328--32",

number = "3",

}

TY - JOUR

T1 - Baerveldt glaucoma implant in paediatric patients

AU - van Overdam, K A

AU - de Faber, J T H N

AU - Lemij, H G

AU - de Waard, P W T

PY - 2006/3

Y1 - 2006/3

N2 - AIM: To evaluate the Baerveldt glaucoma implant (BGI) in paediatric glaucoma treatment.METHODS: In a retrospective non-comparative case series 55 eyes of 40 consecutive paediatric patients (< or =16 years) with primary or secondary glaucoma underwent Baerveldt (350 mm2) implantation. Surgical outcome was evaluated by Kaplan-Meier table analysis.RESULTS: The overall success rate was 80% at last follow up, with a mean follow up of 32 (range 2-78) months. Cumulative success was 94% at 12 months and 24 months, 85% at 36 months, 78% at 48 months, and 44% at 60 months. 11 eyes (20%) failed postoperatively because of an IOP >21 mm Hg (eight eyes), persistent hypotony (two eyes), and choroidal haemorrhage following cataract surgery (one eye). The most frequent complication needing surgery was tube related (20%). A new observation was mild to moderate dyscoria in 22% of the eyes, all buphthalmic, caused by entrapment of a tuft of peripheral iris in the tube track.CONCLUSIONS: The BGI is effective and safe in the management of primary and secondary glaucoma. When angle surgery has proved to be unsuccessful or inappropriate in paediatric patients, a BGI is a good treatment option. One must be prepared to deal with the tube related problems.

AB - AIM: To evaluate the Baerveldt glaucoma implant (BGI) in paediatric glaucoma treatment.METHODS: In a retrospective non-comparative case series 55 eyes of 40 consecutive paediatric patients (< or =16 years) with primary or secondary glaucoma underwent Baerveldt (350 mm2) implantation. Surgical outcome was evaluated by Kaplan-Meier table analysis.RESULTS: The overall success rate was 80% at last follow up, with a mean follow up of 32 (range 2-78) months. Cumulative success was 94% at 12 months and 24 months, 85% at 36 months, 78% at 48 months, and 44% at 60 months. 11 eyes (20%) failed postoperatively because of an IOP >21 mm Hg (eight eyes), persistent hypotony (two eyes), and choroidal haemorrhage following cataract surgery (one eye). The most frequent complication needing surgery was tube related (20%). A new observation was mild to moderate dyscoria in 22% of the eyes, all buphthalmic, caused by entrapment of a tuft of peripheral iris in the tube track.CONCLUSIONS: The BGI is effective and safe in the management of primary and secondary glaucoma. When angle surgery has proved to be unsuccessful or inappropriate in paediatric patients, a BGI is a good treatment option. One must be prepared to deal with the tube related problems.

KW - Adolescent

KW - Antihypertensive Agents/administration & dosage

KW - Child

KW - Child, Preschool

KW - Combined Modality Therapy

KW - Filtering Surgery/methods

KW - Glaucoma/congenital

KW - Glaucoma Drainage Implants/adverse effects

KW - Humans

KW - Infant

KW - Infant, Newborn

KW - Intraocular Pressure

KW - Prosthesis Implantation/methods

KW - Reoperation

KW - Retrospective Studies

KW - Treatment Failure

KW - Treatment Outcome

U2 - 10.1136/bjo.2005.078832

DO - 10.1136/bjo.2005.078832

M3 - Article

C2 - 16488956

SN - 0007-1161

VL - 90

SP - 328

EP - 332

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

IS - 3

ER -

Baerveldt glaucoma implant in paediatric patients

Abstract

Keywords

Access to Document

Fingerprint

Cite this